title: DNMT1 genetic polymorphisms affect breast cancer risk in the central European Caucasian population.
abstract: BACKGROUND
  DNA methylation of CpG islands within the promoter region of genes is an epigenetic modification with an important role in the development of cancer and it is typically mediated by DNA methyltransferases (DNMTs). In cancer cells, global hypomethylation of the genome as a whole and regional hypermethylation of CpG islands have been reported. Four groups of DNMTs have been identified: DNMT1, DNMT2 (TRDMT1), DNMT3A and DNMT3B. DNMT2 uses the catalytic mechanism of DNMTs, but does in fact methylate RNA. Little is known about the significance of these genes in human breast cancer. In the study presented herein, we analyzed five distinct DNMT single SNPs with regard to potential associations with breast cancer risk.
  
  
  METHODS
  In this study, we genotyped 221 female Caucasian breast cancer patients and 221 female Caucasian healthy controls, and we used five allele-specific real-time polymerase chain reaction (qPCR) assays. We selected one locus within the DNMT1 gene and two loci within the DNMT3A and DNMT3B genes, respectively. Statistics were calculated using the chi-squared and Fisher's exact tests, and correlated with clinical parameters such as age, diagnosis, histology, TNM stage, hormonal receptor status, human epidermal growth factor receptor 2 (HER2) status, response to treatment and survival. Statistically significant results were obtained for correlations with the DNMT1 gene.
  
  
  RESULTS
  Five genomic loci within the DNMT1, DNMT3A and DNMT3B genes were assessed. Statistical significance (P = 0.030) was identified for DNMT1 SNP (A201G, rs2228612): six women within the control group were GG homozygous (variant), while this mutation was absent in the breast cancer group.
  
  
  CONCLUSIONS
  We conclude that women with the DNMT1 SNP (A201G, rs2228612) GG homozygous genotype (variant) have a lower risk of developing breast cancer compared to heterozygous or wildtype genotypes. To date, alterations within the DNMT1 gene have not been reported to be associated with cancer in the Caucasian population.
authors: Department of Internal Medicine, Division of Immunotherapy and Gene Therapy, José Carreras Research Center, Saarland University Medical Center, Homburg/Saar D-66421, Germany. mahlknecht@gmx.de.
authors: Kathrin
authors: K
authors: Kullmann
authors: Mustafa
authors: M
authors: Deryal
authors: Mei Fang
authors: MF
authors: Ong
authors: Werner
authors: W
authors: Schmidt
authors: Ulrich
authors: U
authors: Mahlknecht
references: Oncologist. 2006 Jan;11(1):1-8
references: 16401708
references: Nucleic Acids Res. 1992 May 11;20(9):2287-91
references: 1594447
references: Carcinogenesis. 2006 Aug;27(8):1661-9
references: 16501248
references: Blood. 2001 Mar 1;97(5):1172-9
references: 11222358
references: Carcinogenesis. 2005 Feb;26(2):403-9
references: 15528220
references: Nucleic Acids Res. 1999 Jun 1;27(11):2291-8
references: 10325416
references: Genes Dev. 2006 Dec 1;20(23):3215-31
references: 17158741
references: J Clin Oncol. 2004 Nov 15;22(22):4632-42
references: 15542813
references: Proc Natl Acad Sci U S A. 2000 May 9;97(10):5237-42
references: 10805783
references: Annu Rev Biochem. 2005;74:481-514
references: 15952895
references: Oncogene. 2001 May 28;20(24):3139-55
references: 11420731
references: Oncogene. 2002 Aug 12;21(35):5400-13
references: 12154403
references: J Natl Cancer Inst. 2000 Sep 20;92(18):1460-1
references: 10995795
references: Breast Cancer Res. 2010;12(6):R110
references: 21194473
references: N Engl J Med. 2010 Dec 16;363(25):2424-33
references: 21067377
references: Int J Cancer. 2003 Jul 1;105(4):527-32
references: 12712445
references: J Mol Biol. 1988 Oct 20;203(4):971-83
references: 3210246
references: Breast Cancer Res Treat. 2010 Jun;121(3):765-9
references: 19798569
references: J Biol Chem. 2001 Aug 24;276(34):32282-7
references: 11427539
references: Breast Cancer Res. 2004;6(4):R390-4
references: 15217506
references: Clin Cancer Res. 2003 Oct 1;9(12):4415-22
references: 14555514
references: Cell Mol Biol Lett. 2005;10(4):631-47
references: 16341272
references: BMJ. 2000 Sep 9;321(7261):624-8
references: 10977847
references: PLoS Genet. 2013;9(3):e1003284
references: 23544014
references: Genet Mol Res. 2012 Dec 17;11(4):4330-41
references: 23079992
references: Mol Cancer. 2008 Jan 25;7:15
references: 18221536
references: Cancer Res. 2002 Sep 1;62(17):4992-5
references: 12208751
references: Clin Breast Cancer. 2010 Oct 1;10(5):373-7
references: 20920981
references: Eur J Cancer. 2007 Jan;43(1):210-9
references: 17071074
references: RNA. 2008 Aug;14(8):1663-70
references: 18567810
references: J Mammary Gland Biol Neoplasia. 2010 Mar;15(1):5-17
references: 20101446
references: Leukemia. 2011 Jul;25(7):1153-8
references: 21415852
references: Science. 2006 Jan 20;311(5759):395-8
references: 16424344
references: Hum Mol Genet. 2000 Oct;9(16):2395-402
references: 11005794
references: Hum Mol Genet. 2007 Apr 15;16 Spec No 1:R28-49
references: 17613546
references: BMC Biol. 2011 May 27;9:31
references: 21619587